Bookmark

Add to MyYahoo RSS

GlaxoSmithKline News

News on GlaxoSmithKline (Ticker: GSK) continually updated from thousands of sources around the net.

2 hrs ago | Value Line

Stock Screen: Conservative Stocks With High Yields - April 23, 2014

Value Line offers a number of proprietary measures to help investors identify so-called conservative stocks, the most notable being the Safety Rank.

Comment?

Related Topix: Financial Markets, Altria Group, Tobacco, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

6 hrs ago | Newsday

AstraZeneca hit by patent expiries

AstraZeneca has posted a drop in first quarter profits after its earnings were by hit by patents expiring on some of its older medicines.

Comment?

Related Topix: Biotech

11 hrs ago | Swissinfo

Football's governing body urged to come clean

Six Swiss People's Party politicians are making headlines after their controversial visit to Iran over Easter.

Comment?

Related Topix: People's Party (Spain), Biotech

Wed Apr 23, 2014

News Observer

GSK, Novartis and Lilly swap business units in pharmaceutical reshuffling

The Aug. 12, 2005 file photo shows the logo of Swiss company Novartis in Basel, Switzerland.

Comment?

Related Topix: Biotech, Novartis, Noven Pharmaceuticals, Medicine, Influenza, Health

Reuters

Novartis-GSK asset swap offers template for pharma and beyond

The loud welcome given by investors to this week's deal for Novartis and GlaxoSmithKline to trade more than $20 billion of assets could trigger more pacts in the pharmaceuticals sector and beyond.

Comment?

Related Topix: Biotech

Seeking Alpha

Novartis, GlaxoSmithKline Exchange Boosts Both Companies' Stocks, 2014 Outlook

Novartis and GlaxoSmithKline exchanged more than $20 billion in assets recently to reinforce their profitable divisions and eliminate their weaker businesses as drug manufacturers adjust to competition from generics and spending cuts in healthcare.

Comment?

Related Topix: Biotech, Novartis, Medicine, GlaxoSmithKline, Healthcare Industry, Cancer, Health, Leukemia, Breast Cancer

BioSpace

Novartis AG Deal Makes GlaxoSmithKline's Pennsylvania Staffers Nervous

GlaxoSmithKline might be laying workers off but, others are hiring too! Check it out! GlaxoSmithKline's mutlibillion-dollar deal with Novartis announced Tuesday morning is expected to impact the drug company's workers in western Montgomery County the most.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Novartis, Montgomery County, PA, Philadelphia, PA

Hindustan Times

India businesses unlikely to be affected immediately

While Novartis AG, GlaxoSmithKline and Eli Lilly are unclear about the long-term impact of deal on their India businesses, there is unlikely to be any direct or immediate impact.

Comment?

Related Topix: Biotech

Express India

GlaxoSmithKline Asia slashes price of Crocin tablets

GlaxoSmithKline Asia has slashed the price of fever and pain-relief pill Crocin Advance tablets across the country by around 50 per cent in order to conform to the price notified under DPCO, 2013.

Comment?

Related Topix: Biotech

Canadian Business Magazine

Asia shares mixed on lacklustre China data; Japan buoyed by yen, Seibu IPO

Shares were mixed in Asia on Wednesday, as weak data from China sapped upward momentum from an overnight rally on a flurry of deals in the pharmaceutical sector.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Eli Lilly

Tue Apr 22, 2014

AmericanBankingNews.com

GlaxoSmithKline plc Upgraded to Buy at Panmure Gordon

A number of other analysts have also recently weighed in on GSK. Analysts at Zacks downgraded shares of GlaxoSmithKline plc from a "neutral" rating to an "underperform" rating in a research note on Friday, February 21st.

Comment?

Related Topix: Biotech, GlaxoSmithKline, Medicine, Healthcare Industry

BioSpace

GlaxoSmithKline Under Growing Pressure From UK Authorities, Lawyers Warn

British drug giant GlaxoSmithKline will come under more pressure from prosecutors in the UK and US after admitting that it is investigating bribery allegations in several countries, legal experts have said.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

BioSpace

GlaxoSmithKline And Theravance, Inc. Announce Phase III Study Of...

GlaxoSmithKline and Theravance, Inc. today announced the start of a Phase III efficacy and safety study of a combination treatment of the inhaled corticosteroid , fluticasone furoate and long-acting beta2 agonist , vilanterol .

Comment?

Related Topix: Biotech, Startups, Medicine, Theravance, GlaxoSmithKline, Healthcare Industry, Fluticasone (generic), Flovent, Copd, Health, Chronic Obstructive Pulmonary Disease

SFGate

Pharma deals give stocks a lift

Amid a relative dearth of economic data and the lack of fresh news in Ukraine, investors are focusing on the latest batch of U.S. corporate earnings and the slew of developments in the pharmaceuticals industry.

Comment?

Related Topix: Financial Markets, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Business News

TheStreet.com

Making Sense of Novartis and GlaxoSmithKline's Web of Deals

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Mozilla

TheStreet.com

Why GlaxoSmithKline (GSK) Stock Is Higher This Morning

Novartis shares are up 1.11% to $86.41 Novartis said it will buy GlaxoSmithKline's oncology products for $14.5 billion, and sell to GSK its vaccines, excluding flu, for $7.1 billion plus royalties.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, Oncology, Financial Markets

Live Charts

Broker tips: AstraZeneca, GlaxoSmithKline, Shire, Pets at Home

Societe Generale has kept a 'sell' recommendation on AstraZeneca , questioning the reasoning behind a potential takeover by US pharmaceutical peer Pfizer.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry, AstraZeneca Group

MarketWatch

Europe Markets: Drug stocks drive European markets higher

Drug makers took center stage in European trading Tuesday, with shares of AstraZeneca PLC climbing on news of a potential takeover bid, and GlaxoSmithKline PLC rising as it sells one of its units in a multibillion-dollar deal.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, AstraZeneca Group, Healthcare Industry, GlaxoSmithKline, Stanley, Pfizer

Wall Street Journal

Big Brands Unite in Novartis, GlaxoSmithKline Consumer-Health Joint Venture

In combining their consumer-health businesses, GlaxoSmithKline PLC and Novartis AG are creating a giant that unites some of the world's best-known brands.

Comment?

Related Topix: GlaxoSmithKline, Biotech, Medicine, Healthcare Industry

BBC News

Novartis in $16bn GSK division deal

Novartis and GlaxoSmithKline, two of the world's leading drugmakers, have agreed to exchange assets and combine their consumer healthcare units.

Comment?

Related Topix: Biotech, Medicine, GlaxoSmithKline, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••